Supratentorial ICH outcomes better in young blacks, hispanics

Supratentorial ICH outcomes better in young blacks, hispanics

January 23, 2020 Supratentorial ICH outcomes better in young blacks, hispanics (HealthDay)—For young adults with supratentorial intracerebral hemorrhage (ICH), functional outcomes are improved with black and Hispanic versus white race/ethnicity, according to a study published online Jan. 22 in Neurology . Laura C. Miyares, from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined predictors of functional outcome in young patients enrolled in the Ethnic/Racial Variations in Intracerebral Hemorrhage prospective multicenter study, including non-Hispanic white, non-Hispanic black, and Hispanic adults. A subset of 418 participants aged <50 years with supratentorial ICH were included in the analyses (12 percent white; 41 percent black; and 47 percent Hispanic). The researchers found that black and Hispanic participants had better outcomes than white participants for supratentorial ICH (odds ratios, 0.42 and 0.34, respectively) after adjustment for other factors associated with poor outcome, including age, baseline disability, admission blood pressure, admission Glasgow Coma Scale score, ICH volume, deep ICH location, and intraventricular extension. "Despite reports that minority patients fare better due to an average younger age at ICH onset, our results demonstrate that differences in functional recovery by race/ethnicity persist even when studying a young adult population," the authors write. "This may indicate distinct pathophysiologies of the initial bleed or unique mechanisms of secondary injury across different racial/ethnic groups." Explore further



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More